NOVACYT
ロング

Novacyt ALNOV

They have marked the supports and resistances of ALNOV.
It has great upside potential, key level reaching $ 5
Last Friday news Clinical diagnostics specialist Novacyt announced on Friday thatots ‘genesig’ Covid-19 real-time PCR test has been approved in the UK.
I send you a cordial greeting, Merry Christmas and a prosperous 2022
In Spain on 12/23/2021
ALNOVCoronavirus (COVID-19)covidstockseuropefranceFundamental AnalysishealthstocksTechnical IndicatorsomicrontestTrend AnalysisUK

他のメディア:

免責事項